Next Article in Journal
Predictors of Methotrexate Success and Fertility Outcomes in Tubal Ectopic Pregnancy: A Retrospective Cohort Study
Previous Article in Journal
Use of JAK Inhibitors in Lichen Planus: An Update
Previous Article in Special Issue
The Role of Medical Therapies in the Management of Cervical Intraepithelial Neoplasia: A Narrative Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Editorial for Special Issue “Diagnosis and Treatment of Cervical Cancer”

by
Giorgia Perniola
and
Tullio Golia D’Augè
*
Department of Maternal and Child Health and Urological Sciences, Sapienza University of Rome, Policlinico Umberto I, 00161 Rome, Italy
*
Author to whom correspondence should be addressed.
Medicina 2025, 61(6), 1057; https://doi.org/10.3390/medicina61061057
Submission received: 10 May 2025 / Revised: 29 May 2025 / Accepted: 5 June 2025 / Published: 9 June 2025
(This article belongs to the Special Issue Diagnosis and Treatment of Cervical Cancer)
Cervical cancer remains one of the most significant gynecologic malignancies worldwide, particularly impacting women in their reproductive years [1]. Despite the widespread use of HPV vaccination and cervical screening programs, the disease burden remains high, especially in low-resource settings [2,3]. Advances in diagnostic technologies, conservative management strategies, and tailored surgical approaches have modified the clinical landscape, aiming to improve oncologic outcomes while preserving fertility and quality of life in affected patients [4,5,6,7,8].
This Special Issue features five original contributions that address the present critical challenges in the prevention, diagnosis, and treatment of cervical intraepithelial neoplasia (CIN) and early cervical cancer (CC). These works highlight the gynecologic community’s continued commitment to refining conservative and surgical approaches in order to improve oncological outcomes and preserve reproductive potential.
The retrospective study by Ferrari et al. compared cold knife (CK) and CO2 laser conization for preinvasive cervical lesions, showing a significantly lower rate of positive endocervical or deep margins with CO2 laser [9]. Notably, both techniques demonstrated oncological safety in cases of incidental early-stage cervical cancer, highlighting their potential role in fertility-sparing treatment strategies.
A comprehensive systematic review by D’Amato et al. analyzed the reproductive outcomes of fertility-sparing treatments (FSTs) in women with tumors >2 cm [10]. Although a meta-analysis could not be performed due to significant data heterogeneity, the authors emphasized a consistent correlation between oncological and reproductive outcomes according to the surgical approach, underscoring the need for future evidence-based recommendations in this specific patient subgroup.
Rotar et al. reviewed the topical treatment landscape for CIN, emphasizing the potential of locally administered agents as alternatives to surgery in selected cases [11]. Their findings underscore the growing interest in conservative therapies aimed at reducing obstetrical complications associated with demolitive procedures.
The prospective observational study by Vitkauskaite et al. explored the role of inflammation in cervical cancer pathogenesis and staging [12]. By analyzing serum concentrations of IL-6, TREM-1, and LCN2 in patients with cervical cancer compared to healthy controls, the authors recognized these markers as independent predictors of the diagnosis of cervical cancer and advanced-stage disease. Their findings suggest the potential utility of systemic inflammatory mediators as cost-effective tools for diagnosis and risk stratification in cervical cancer patients.
Finally, Dicu-Andreescu et al. conducted a retrospective–prospective study on a cohort of 96 patients with cervical cancer stages IA2 to IIIB, treated with neoadjuvant chemo-radiotherapy followed by radical surgery [13]. The authors investigated FIGO stage, residual tumor, stromal and lymphovascular invasion, and resection margin status as patient-related characteristics affecting 3-year survival. Their findings showed that positive resection margins and post-radiotherapy FIGO stage III were independent predictors of modest outcomes. In patients treated with neoadjuvant therapy, the high rate of residual tumor at surgery highlights the importance of tailoring surgical strategies—even in advanced disease—according to individual patient characteristics.
Collectively, these contributions advance our understanding of cervical pathology management, offering new perspectives for clinicians striving to balance oncologic radicality and fertility preservation. We hope this Special Issue will inspire further research and guide future clinical practice in the evolving field of gynecologic oncology.

Author Contributions

Conceptualization, G.P. and T.G.D.; validation, G.P.; writing—original draft preparation, T.G.D.; writing—review and editing, T.G.D. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Acknowledgments

We extend our sincere gratitude to all the authors, reviewers, and the editorial team of Medicina for their commitment and scientific rigor.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
CINCervical intraepithelial neoplasia
CCCervical cancer
CKCold knife
FSTFertility-sparing treatments
HPVHuman papilloma virus

References

  1. Cervical Cancer. Available online: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer (accessed on 6 May 2025).
  2. Jensen, J.E.; Becker, G.L.; Jackson, J.B.; Rysavy, M.B. Human Papillomavirus and Associated Cancers: A Review. Viruses 2024, 16, 680. [Google Scholar] [CrossRef] [PubMed]
  3. Cibula, D.; Raspollini, M.R.; Planchamp, F.; Centeno, C.; Chargari, C.; Felix, A.; Fischerová, D.; Jahnn-Kuch, D.; Joly, F.; Kohler, C.; et al. ESGO/ESTRO/ESP Guidelines for the Management of Patients with Cervical Cancer—Update 2023. Int. J. Gynecol. Cancer 2023, 33, 649–666. [Google Scholar] [CrossRef] [PubMed]
  4. Cibula, D.; Dusek, J.; Jarkovsky, J.; Dundr, P.; Querleu, D.; van der Zee, A.; Kucukmetin, A.; Kocian, R. A Prospective Multicenter Trial on Sentinel Lymph Node Biopsy in Patients with Early-Stage Cervical Cancer (SENTIX). Int. J. Gynecol. Cancer 2019, 29, 212–215. [Google Scholar] [CrossRef]
  5. Dio, C.D.; Azenkoud, I.; Trezza, A.; Lentini, E.; D’Augè, T.G.; Cuccu, I.; Bartolomeo, G.D.; Firulli, I.; Canicchio, A.; Sgamba, L.; et al. Early-Stage Cervical Cancer Treatment—What’s New? Prz. Menopauzalny 2023, 22, 87–92. [Google Scholar] [CrossRef]
  6. Plante, M.; Kwon, J.S.; Ferguson, S.; Samouëlian, V.; Ferron, G.; Maulard, A.; de Kroon, C.; Van Driel, W.; Tidy, J.; Williamson, K.; et al. Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer. N. Engl. J. Med. 2024, 390, 819–829. [Google Scholar] [CrossRef]
  7. Golia D’Augè, T.; Caruso, G.; Laudani, M.E.; Nazzaro, L.; De Vitis, L.A.; Rosanu, N.M.; Ribero, L.; Alessi, S.; Lazzari, R.; Betella, I.; et al. Para-Aortic Lymph Node Recurrence in Surgically Treated Early-Stage Cervical Cancer without Para-Aortic Lymph Node Surgical Staging. Int. J. Gynecol. Cancer 2024, 34, 1867–1873. [Google Scholar] [CrossRef] [PubMed]
  8. Manganaro, L.; Nicolino, G.M.; Dolciami, M.; Martorana, F.; Stathis, A.; Colombo, I.; Rizzo, S. Radiomics in Cervical and Endometrial Cancer. Br. J. Radiol. 2021, 94, 20201314. [Google Scholar] [CrossRef] [PubMed]
  9. Ferrari, F.; Bonetti, E.; Oliveri, G.; Giannini, A.; Gozzini, E.; Conforti, J.; Ferrari, F.A.; Salinaro, F.; Tisi, G.; Ciravolo, G.; et al. Cold Knife Versus Carbon Dioxide for the Treatment of Preinvasive Cervical Lesion. Medicina 2024, 60, 1056. [Google Scholar] [CrossRef] [PubMed]
  10. D’Amato, A.; Riemma, G.; Agrifoglio, V.; Chiantera, V.; Laganà, A.S.; Mikuš, M.; Dellino, M.; Maglione, A.; Faioli, R.; Giannini, A.; et al. Reproductive Outcomes in Young Women with Early-Stage Cervical Cancer Greater than 2 Cm Undergoing Fertility-Sparing Treatment: A Systematic Review. Medicina 2024, 60, 608. [Google Scholar] [CrossRef] [PubMed]
  11. Rotar, I.C.; Boitor Borza, D.; Staicu, A.; Goidescu, I.G.; Nemeti, G.I.; Iulia, P.; Mitranovici, M.I.; Daniel, M.; Aida, P. The Role of Medical Therapies in the Management of Cervical Intraepithelial Neoplasia: A Narrative Review. Medicina 2025, 61, 326. [Google Scholar] [CrossRef]
  12. Vitkauskaite, A.; Urboniene, D.; Celiesiute, J.; Jariene, K.; Paskauskas, S.; Vaitkiene, D.; Vitkauskiene, A. Expression of Inflammation Depending on the Stage of Cervical Cancer. Medicina 2024, 60, 349. [Google Scholar] [CrossRef] [PubMed]
  13. Dicu-Andreescu, I.-G.; Marincaș, M.-A.; Prunoiu, V.-M.; Dicu-Andreescu, I.; Ionescu, S.-O.; Simionescu, A.-A.; Brătucu, E.; Simion, L. The Impact of Patient Characteristics, Risk Factors, and Surgical Intervention on Survival in a Cohort of Patients Undergoing Neoadjuvant Treatment for Cervical Cancer. Medicina 2023, 59, 2147. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Perniola, G.; D’Augè, T.G. Editorial for Special Issue “Diagnosis and Treatment of Cervical Cancer”. Medicina 2025, 61, 1057. https://doi.org/10.3390/medicina61061057

AMA Style

Perniola G, D’Augè TG. Editorial for Special Issue “Diagnosis and Treatment of Cervical Cancer”. Medicina. 2025; 61(6):1057. https://doi.org/10.3390/medicina61061057

Chicago/Turabian Style

Perniola, Giorgia, and Tullio Golia D’Augè. 2025. "Editorial for Special Issue “Diagnosis and Treatment of Cervical Cancer”" Medicina 61, no. 6: 1057. https://doi.org/10.3390/medicina61061057

APA Style

Perniola, G., & D’Augè, T. G. (2025). Editorial for Special Issue “Diagnosis and Treatment of Cervical Cancer”. Medicina, 61(6), 1057. https://doi.org/10.3390/medicina61061057

Article Metrics

Back to TopTop